Use of PET-CT for the assessment of treatment results in patients with sarcoidosis

YAKAR, AysunYAKAR, FatihSEZER, MuratBayram, MEHMETErdogan, EZGİ BAŞAKOzkan, DİDEMOZCELIK, Hatice K.TABAK, Levent2019-10-052019-10-052015-04-01YAKAR A., YAKAR F., SEZER M., Bayram M., Erdogan E. B. , Ozkan D., OZCELIK H. K. , TABAK L., -Use of PET-CT for the assessment of treatment results in patients with sarcoidosis-, WIENER KLINISCHE WOCHENSCHRIFT, cilt.127, ss.274-282, 2015https://hdl.handle.net/20.500.12645/9525Background and aim Sarcoidosis is a multisystem disease of unknown origin. Determining the involvement and the response to the treatment is important. The aim of this study was to identify the effects of methylprednisolone and indomethacine on metabolic activity and pulmonary function test parameters in patients with sarcoidosis.enUse of PET-CT for the assessment of treatment results in patients with sarcoidosisArticleWOS:0003545491000078493995038810.1007/s00508-014-0647-9